Table 2.
Baseline | The first visit(3 Months) | The second visit (6 Months) | The third visit (9 Months) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SMS N (%) |
Control N (%) |
χ 2 | SMS N (%) |
Control N (%) |
χ 2 | SMS N (%) |
Control N (%) |
χ 2 | SMS N (%) |
Control N (%) |
χ 2 | |
Condomless anal intercourse | ||||||||||||
Yes | 129(40.69)a | 120(38.22)a,b | 0.405 | 71(24.48)b | 129(44.33)b | 25.346* | 42(14.19)c | 103(35.15)a,b | 34.873* | 37(14.18)c | 81(28.42)a | 16.318* |
No | 188(59.31) | 194(61.78) | 219(75.52) | 162(55.67) | 254(85.81) | 190(64.85) | 224(85.82) | 204(71.58) | ||||
Number of male partners | ||||||||||||
0–1 | 133(41.96) | 139(44.27) | 0.344 | 61(21.03) | 45(15.46) | 3.022 | 91(30.74) | 45(15.36) | 19.626* | 71(27.20) | 44(15.44) | 11.341* |
≥ 2 | 184(58.04)a | 175(55.73)a | 229(78.97)b | 246(84.54)b | 205(69.26)c | 248(84.64)b | 190(72.80)b,c | 241(84.56)b | ||||
Sex with male infector | ||||||||||||
Yes | 6(1.89) | 2(0.64) | 2.000 | 6(2.07) | 2(0.69) | 8.737* | 4(1.35) | 1(0.34) | 26.224* | 8(3.07) | 5(1.75) | 12.980* |
No | 193(60.88) | 195(62.10) | 212(73.10) | 187(64.26) | 254(85.81) | 205(69.97) | 224(85.82) | 216(75.79) | ||||
Unclear | 118(37.22)a | 117(37.26)a | 72(24.83)b | 102(35.05)a | 38(12.84)c | 87(29.69)a,b | 29(11.11)c | 64(22.46)b | ||||
Condomless oral sex | ||||||||||||
Yes | 174(54.89)a | 172(54.78)a,b | 0.001 | 174(60.00)a | 182(62.54)b | 0.396 | 168(56.76)a | 148(50.51)a | 2.309 | 158(60.53)a | 144(50.53)a | 5.523* |
No | 143(45.11) | 142(45.22) | 116(40.00) | 109(37.46) | 128(43.24) | 145(49.49) | 103(39.46) | 141(49.47) | ||||
Condom use in last intercourse | ||||||||||||
Yes | 240(75.71)a | 249(79.3)a | 1.165 | 265(91.38)b | 260(89.35)b | 0.689 | 269(90.88)b | 260(88.74)b | 0.738 | 244(93.48)b | 254(89.12)b | 3.235 |
No | 77(24.29) | 65(20.7) | 25(8.62) | 31(10.65) | 27(9.12) | 33(11.26) | 17(6.51) | 31(10.88) | ||||
New-type drug used | ||||||||||||
Yes | 100(31.55)a | 88(28.03)a | 0.334 | 72(24.83)a | 90(30.93)a | 2.688 | 71(23.99)a | 87(29.69)a | 2.443 | 64(24.52)a | 82(28.77)a | 1.257 |
No | 217(68.45) | 226(71.97) | 218(75.17) | 201(69.07) | 225(76.01) | 206(70.31) | 197(75.48) | 203(71.23) | ||||
Group intercourse | ||||||||||||
Yes | 38(11.99)a | 37(11.78)a | 0.935 | 20(6.90)a,b | 29(9.97)a | 1.772 | 13(4.39)b | 27(9.22)a | 5.411* | 15(5.75)a,b | 24(8.42)a | 1.469 |
No | 279(88.01) | 277(88.22) | 270(93.10) | 262(90.03) | 283(95.61) | 266(90.78) | 246(94.25) | 261(91.58) | ||||
Commercial sex | ||||||||||||
Yes | 11(3.47)a | 16(5.10)a | 1.018 | 7(2.41)a | 7(2.44)a,b | 0.000 | 4(1.35)a | 2(0.68)b | 0.653 | 6(2.30)a | 2(0.70)b | 2.407 |
No | 306(96.53) | 298(94.90) | 283(97.59) | 284(97.56) | 292(98.6) | 291(99.32) | 255(97.70) | 283(99.30) |
Ps: (1)a vs. b, P < 0.05; (2) a vs. c, P < 0.05; (3) a vs. b,c, P < 0.05; (4) a vs. a,b, P ≥ 0.05; (5) b vs. a,b, P ≥ 0.05, (6) b vs. b,c, P ≥ 0.05; *: the SMS group vs. the control group, P < 0.05